Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - authors' reply
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
1 December 2017
|
| In: |
The lancet. Oncology
Year: 2017, Volume: 18, Issue: 12, Pages: e709-e710 |
| ISSN: | 1474-5488 |
| DOI: | 10.1016/S1470-2045(17)30856-2 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/S1470-2045(17)30856-2 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1470204517308562 
|
| Author Notes: | Michael Weller, Nicholas Butowski, David D Tran, Lawrence D Recht, Michael Lim, Hal Hirte, Lynn Ashby, Laszlo Mechtler, Samuel A Goldlust, Fabio Iwamoto, Jan Drappatz, Donald M O'Rourke, Mark Wong, Mark G Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, Christopher D Turner, Michael J Yellin, Tibor Keler, Thomas A Davis, Roger Stupp, John H Sampson |
| Item Description: | Gesehen am 26.11.2018 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1474-5488 |
| DOI: | 10.1016/S1470-2045(17)30856-2 |